MEDICINE DETAILS
Leqvio
Active ingredient: Inclisiran
Official EMA and FDA records identify Leqvio as an inclisiran solution for subcutaneous injection. The recorded presentation contains 284 mg in 1.5 mL in one pre-filled syringe.
NEXT STEP
Choose the strength and pack
✓ If you are unsure, choose “I do not know”.
These options are not medical advice, a dosing recommendation, stock confirmation or a sale offer.
ABOUT THIS MEDICINE
What is Leqvio used for?
Leqvio (inclisiran) is a small interfering ribonucleic acid (siRNA) medication indicated for the treatment of adults with primary hypercholesterolemia or mixed dyslipidemia (conditions that cause high levels of fats, including cholesterol, in the blood). Leqvio (inclisiran) reduces cholesterol in the blood.
It is given in addition to a cholesterol-lowering diet. Leqvio (inclisiran) is used:
- Together with a statin (a cholesterol-lowering medicine), sometimes combined with another cholesterol-lowering treatment if the maximum dose of the statin does not work well enough, or
- Alone or together with other cholesterol-lowering medicines when statins do not work well or cannot be used.
It is available as a pre-filled syringe for under-the-skin (subcutaneous) injection, containing 284 mg inclisiran in 1.5 ml solution.
This information is general and is not medical advice. Talk to your doctor or pharmacist about any treatment decision.
RECORDED PRODUCT PROFILE
Leqvio identity, dosage form and pack information.
The details below are assembled from current catalogue records. They must still be checked against the prescription, medicine box and an official regulatory record.
OFFICIAL RECORD SUMMARY
Product details checked against regulatory sources
Official EMA and FDA records identify Leqvio as an inclisiran solution for subcutaneous injection. The recorded presentation contains 284 mg in 1.5 mL in one pre-filled syringe.
- ✓Solution for subcutaneous injection
- ✓284 mg/1.5 mL
- ✓One pre-filled syringe
Presentations can differ by jurisdiction and authorisation. This list is not a use or dosing recommendation.
Recorded strength and pack options
Each row is shown only to help identify the product; it is not stock confirmation or a sale offer.
-
284 mg solution for injection · 1 pre-filled syringe (1.5 ml) Catalogue organisation: PARANOVA PACK A/S
OFFICIAL SOURCES
Check the Leqvio record at an official source.
Search for “Leqvio” or “Inclisiran”. Finding a product in one source does not by itself confirm stock, authorisation in a particular country or suitability for a patient.
OFFICIAL EXTERNAL SOURCE
European Medicines Agency (EMA)
Search medicines evaluated by EMA by brand name or active substance. EMA also links to national registers for nationally authorised products.
↗ OFFICIAL EXTERNAL SOURCE Drugs@FDASearch FDA-approved human drug records by brand name or active ingredient, including current labelling where available.
↗ PRODUCT-SPECIFIC OFFICIAL RECORD EMA — Leqvio EPAREuropean public assessment information for Leqvio.
↗ PRODUCT-SPECIFIC OFFICIAL RECORD FDA — Leqvio prescribing informationFDA-approved U.S. prescribing information and syringe presentation.
↗SERVICE BOUNDARY
Information checking and independent enquiry support for Leqvio.
OrphanDrug helps organise the product identity and recorded strength and pack details for an enquiry. It does not sell, take payment for, prescribe, import, dispense or deliver medicines.
Clinical decision: Only a qualified healthcare professional who has assessed the patient can decide whether a product, form or dose is appropriate.
CLEAR ANSWERS
Frequently asked questions about Leqvio
01What is Leqvio?＋
This directory record associates the brand name Leqvio with the active ingredient Inclisiran. The brand and ingredient are shown for product identification only, not as treatment or dosing advice.
02Which Leqvio strengths and packs are recorded?＋
The catalogue currently shows: 284 mg solution for injection · 1 pre-filled syringe (1.5 ml). Check the complete strength, dosage form and pack description against the prescription and medicine box.
03Who manufactures Leqvio?＋
Catalogue records currently name: PARANOVA PACK A/S. This field may identify a manufacturer, marketing-authorisation holder, marketing company or supplier; confirm the exact role on the pack leaflet and official regulatory record.
04Do the listed options confirm stock or access?＋
No. A catalogue record does not confirm current stock, authorisation in a particular country, clinical suitability, import permission or access.
05What affects a possible estimated medicine cost for Leqvio?＋
A possible cost depends on the exact strength, dosage form, pack, quantity, destination and regulatory jurisdiction. Any amount provided after an enquiry is an indicative medicine-cost estimate only, not a selling price for Leqvio, payment request, stock guarantee or binding offer.
06Can I buy Leqvio from this website?＋
No. This website does not sell, take payment for, prescribe, import, dispense or deliver medicines. The form creates an independent consultancy enquiry only.